# CF Bankshares Inc.: Form 10-Q for the period ended Sep 30, 2025

- Company: [CF Bankshares Inc.](/companies/cfbk.md) (CIK 1070680)
- Form: 10-Q
- Filed: 2025-11-07
- Accepted by EDGAR: Nov 7, 2025, 09:16 ET
- Period: 2025-09-30
- Accession: 0001193125-25-271208
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070680/000119312525271208/cfbk-20250930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070680/000119312525271208/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Income tax | 3 months, 2025-07-01 to 2025-09-30 | $373.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2025-01-01 to 2025-09-30 | $2.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-07-01 to 2025-09-30 | $2.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2025-01-01 to 2025-09-30 | $11.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-07-01 to 2025-09-30 | $0.36 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2025-01-01 to 2025-09-30 | $1.81 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-07-01 to 2025-09-30 | $0.36 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2025-01-01 to 2025-09-30 | $1.82 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-07-01 to 2025-09-30 | 6,346,243 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2025-01-01 to 2025-09-30 | 6,325,600 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2025-01-01 to 2025-09-30 | $15.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2025-01-01 to 2025-09-30 | $432.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2025-01-01 to 2025-09-30 | $1.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2025-09-30 | $272.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2025-09-30 | $2.11bn | us-gaap:Assets |
| Total liabilities | at 2025-09-30 | $1.93bn | us-gaap:Liabilities |
| Shareholders' equity | at 2025-09-30 | $179.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,529 characters.

(a) None.

(b) Not applicable.

(c) The following table provides information concerning purchases of the Holding Company’s shares of common stock made by or on behalf of the Company or any “affiliated purchaser” as defined in Rule 10b-18(a)(3) under the Exchange Act, during the three months ended September 30, 2025.

| Period | Total number of common shares purchased |  | Average price paid per common share | Total number of common shares purchased as part of publicly announced plans or programs (2) | Maximum number of common shares that may yet be purchased under the plans or programs |
| --- | ---: | ---: | ---: | ---: | ---: |
| July 1, 2025 through July 31, 2025 | 3,425 | (1) | 23.49 | 3,240 | 289,622 |
| August 1, 2025 through August 31, 2025 | — |  | — | — | 289,622 |
| September 1, 2025 through September 30, 2025 | — |  | — | — | 289,622 |
| Total | 3,425 |  | $23.49 | 3,240 |  |

(1) Includes 185 shares of common stock surrendered to the Company for the payment of taxes upon the vesting of restricted stock and 3,240 shares of common stock repurchased under the stock repurchase program.

(2) On February 4, 2025, the Company's Board of Directors authorized a new stock repurchase program pursuant to which the Company is authorized to repurchase up to an aggregate of 325,000 shares, or approximately 5% of the Company's outstanding common stock, on or before January 31, 2026. As of September 30, 2025, 289,622 shares remained available to be purchased by the Company under this stock repurchase program.

## Risk factors

As filed, 459 characters.

There are certain risks and uncertainties in our business that could cause our actual results to differ materially from those anticipated. A detailed discussion of our risk factors is included in “Item 1A. Risk Factors” of Part I of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. There were no material changes to those risk factors as presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Filed Nov 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-271208. Last ingested by Listed: Nov 13, 2026, 01:50 ET. No prices; not investment advice.
